Needle for body fluid tester

Information

  • Patent Grant
  • 6802199
  • Patent Number
    6,802,199
  • Date Filed
    Thursday, June 27, 2002
    22 years ago
  • Date Issued
    Tuesday, October 12, 2004
    20 years ago
Abstract
An apparatus for collecting a body fluid for testing for an analyte includes a needle for penetrating a patient's skin to access the fluid within the skin. The needle has a hollow body extending from a first end to a second end. An interior surface of the body defines a fluid pathway extending between the ends. The second end is positioned to deposit fluid for testing. The first end has a beveled face on a front side of the body. The beveled face terminates at a penetration tip with the beveled face having an opening in communication with the fluid pathway. The penetration tip is burnished to a rounded shape and bent to facilitate low pain and rapid fluid collection.
Description




TECHNICAL FIELD




This invention pertains to testing a body fluid for an analyte. More specifically, the present invention pertains to a novel needle design in combination with a collection apparatus for collecting a sample of such a fluid.




BACKGROUND




Numerous patents teach various ways for collecting a sample of body fluid and testing such fluid for an analyte such as glucose. For example, U.S. Pat. Nos. 5,820,570 and 5,823,973 describe methods and apparatus for obtaining, in one embodiment, interstitial fluid which is tested for glucose through IR absorption. These patents also describe use of the disclosed inventions in colormetric and electro-chemical testing of glucose.




Present development efforts are directed to testing very small volumes of body fluid (e.g. about 0.5 μl). The use of such small volumes of fluid permits less painful collection of a fluid samples. However, small fluid volumes present additional challenges for analyte testing. For example, testing for analytes typically requires a fluid sample in excess of a predetermined minimum volume. By way of non-limiting representative example, a test may require a minimum sample size of about 1 to 5 μl to yield reliable test results.




The '973 patent shows a small diameter needle (about 28 to 32 gauge or about 0.36 mm to 0.23 mm outside diameter) with a length to penetrate into but not through a dermis to access interstitial fluid contained within the dermis. Preferably, the fluid is blood-free to facilitate subsequent testing of the fluid for analytes such as glucose.




The use of a small needle dimensioned as described in the '973 patent greatly reduces pain. However, pain may occasionally occur. Further, there is a need for a needle design that enhances the rate at which a sample is collected by such a needle.




SUMMARY




The present invention is directed to an apparatus for collecting a body fluid for testing for an analyte contained within said body fluid. The apparatus comprises a needle for penetrating a patient's skin to access the fluid within said skin. The needle has a hollow body extending from a first end to a second end with a fluid pathway extending between the ends. The second end is positioned to deposit fluid for testing. The first end is configured to penetrate the skin and includes a beveled face on a front side of said body. The beveled face terminates at a penetration tip. The beveled face has an opening in communication with the fluid pathway. The body has a linear axis adjacent the first end. The first end includes a bend formed on the front side of the beveled face to be deflected toward said front side.











BRIEF DESCRIPTION OF THE DRAWINGS





FIG. 1

is a side elevation view of a needle contained in a sampler;





FIG. 2

is a side sectional view of a needle positioned relative to an absorbent membrane;





FIG. 3

is a side elevation view of a needle being bent;





FIG. 4

is a top plan view of a bent needle;





FIG. 5

is a view taken along line


5





5


of

FIG. 4

;





FIG. 5A

is an end view of a discharge end of a bent needle;





FIG. 5B

is a view taken along lines


5


B—


5


B of FIG.


5


A and providing an enlarged view of a bent tip of the needle of FIG.


5


and showing a preferred embodiment with the tip bent above the needle;





FIG. 6

is a side sectional view of a tip of a prior art needle;





FIG. 7

is a top plan view of the needle tip shown in

FIG. 6

; and





FIG. 8

is a side elevation view of the needle shown in

FIGS. 6 and 7

following dulling of the needle tip;





FIG. 9

is a graphical representation of a collection rate as a function of needle tip displacement for a needle such as that shown in

FIGS. 5A and 5B

; and





FIG. 10

is a scatter chart of a collection rate as a function of the bend angle of a needle tip for a needle such as that shown in FIGS.


5


A and


5


B.











DETAILED DESCRIPTION




Various embodiments of the present invention, including a preferred embodiment, will be described in detail with reference to the drawings wherein like reference numerals represent like parts and assemblies throughout the several views. Reference to the described embodiments does not limit the scope of the invention, which is limited only by the scope of the appended claims.




Throughout the following description, an embodiment of the present invention will be described with reference to collecting a sample of interstitial fluid for glucose testing using a narrow needle that penetrates into, but not through, the dermis. Such sample collection is more fully described in commonly assigned U.S. Pat. Nos. 5,823,973 and 5,820,570, the disclosures for both of which are hereby incorporated by reference as though set forth in full. While such a use is a preferred embodiment, the present invention is applicable to other fluid collection systems as well as testing for other fluid analytes.





FIG. 1

illustrates a fluid sampler


410


such as that shown in FIGS. 36-40 of U.S. Pat. No. 5,823,973 (the '973 patent), the disclosure of which is hereby incorporated herein by reference.

FIG. 2

illustrates a membrane and needle assembly such as that shown in

FIG. 43

of the '973 patent. For ease of illustration, the present invention will be described to a needle alignment such as that shown in the '973 patent with the axis of the needle parallel to the surface of an absorbing membrane. The invention could also be used in other arrangements. For example, the needle axis can be perpendicular to the membrane and fluid can flow through the membrane to an opposite side for colormetric testing.




Referring now to

FIGS. 1 and 2

, the sampler


410


has a hollow handle end


409


with an interior


500


to receive a sample end


411


. The sample end


411


pivots on a pin


502


. The sample end


411


then can pivot between a storage position within the hollow handle end


409


and a deployed position.

FIG. 1

shows the sample end


411


pivoted into the deployed position.




The sample end


411


is configured to receive samples such as a fluid. An absorbent membrane


504


is carried on the sample end


411


. The sample end


411


also includes a hub or ferrule


506


that terminates at a ring end


508


. In one possible embodiment, the ring end may serve as a pressure ring. A needle


510


is held by the ferrule


506


. Additionally, the sample end


411


defines a hole


604


(FIG.


2


). An absorbent membrane


504


has a target area T and is arranged so that the target area T overlies the hole


604


.




As shown in

FIG. 3

, the needle


510


includes a hollow, straight tubular body


514


, a first or penetration end


600


, and a discharge end


601


(shown in FIGS.


1


and


2


). In one embodiment, the needle


510


is a 30 gauge needle, about 0.3 mm in outside diameter, although other needle gauges can be used. In a preferred embodiment, the penetration end


600


protrudes from the ring end


508


of the ferrule by a predetermined distance. The predetermined distance is set so that the first end


600


will penetrate into, but not through, a patient's dermis when the ring


508


is placed against his or her skin.




The discharge end


601


abuts an absorbent membrane


504


mounted on the sample end


411


. In this configuration, the longitudinal axis of the needle


510


is perpendicular to the portion of the membrane


504


that forms the target area T. Additionally, the tubular body


514


has an interior surface


511


(

FIG. 5

) that defines a fluid pathway


512


extending completely through the needle body


514


.




In use, the penetration end


600


of the needle


510


is inserted into the patient's dermis. Fluid then flows along the fluid pathway


512


and through the absorbent membrane


504


to the target area T. The absorbent membrane


504


filters out undesirable stray blood cells that may be present in the fluid. The fluid at the target area can then be tested for elements such as glucose.




One possible way to test the fluid is through the use of infrared light. Alternative embodiments include but are not limited to depositing the fluid on a test strip for colormetric testing or on electrodes for electrochemical testing.




Referring to

FIGS. 4 and 5

, the needle


510


has a primary beveled face


520


and tip


530


formed at its penetration end


600


. An entrance hole


521


is formed in the beveled face


520


and is in fluid communication with the fluid path


512


. The needle


510


also has a front side


522


and an opposite back side


523


. The tip


530


of the needle


510


is displaced toward the front side


522


of the needle


510


.




Referring to

FIG. 3

, one possible way to form the needle


510


is as follows. The penetration end


600


of the hollow body


514


is ground at an angle to define the beveled face


520


so that it extends through the body


514


and forms the sharp penetration tip


530


. In one possible embodiment, the beveled face is formed at an angle β (about 9°) with respect to a longitudinal axis CL—CL of the needle body


514


. The formation of a beveled face


520


results in formation of the entrance hole


521


on beveled face


520


. The present invention is shown with a needle having a single grind forming the beveled face. The present invention is also applicable to needles with multiple grinds forming the beveled face.




After providing a needle body


514


with a flat beveled face


520


, a fulcrum


700


is placed at a bend location, which is a distance X from the tip


530


. In one possible embodiment, the distance X is about 1.2 mm, although other distances can be used. The tip


530


is then urged toward the front side


522


to permanently displace the tip


530


and form a bend angle α. When the tip


530


is displaced, it moves from being aligned with a plane of the back side


523


of the body


514


to a location spaced by a distance Y from the plane of the back side


523


. This method creates an arcuate bend which is approximated in the Figures by the bend angle α. In one possible embodiment, the bend angle α is about 27.1°, although other bend angles are possible.




For reasons not fully understood, the use of a displaced tip


530


results in enhanced fluid collection. Possibly, a pocket is formed around the opening


521


to improve fluid flow. Whatever the mechanism, fluid collection is enhanced. Further, the degree of enhancement improves with the amount of deflection Y. The following table illustrates the amount of time required to collect an adequate sample (in the test presumed to be about 0.9 μl of fluid) for an average of needle samples at various tip displacements Y and for a variety of axial locations X (with X and Y as defined with reference to FIG.


3


). The amount of time greatly decreases with an increase in Y. In fact, displacement of the tip above the front plane of the needle body has resulted in enhanced collection. In the following table, negative values of α and Y reflect a backward bending of the tip behind the rear side of the needle. Zero values reflect an unbent needle.












TABLE A











Time to Collect Pre-determined Amount of Sample
















Location




Angle





Time to Collect







X




α




Displacement Y




.9 μl of Sample







(mm)




(degrees)




(mm)




(seconds)




















1.07




−6.03




−0.14




26.75







0




0




0




15.51







0.88




3.24




0.09




12.75







1.57




5.71




0.13




10.41







0.86




11.3




0.15




11.46







2.03




8.13




0.25




12.74







1.30




12.8




0.279




9.04







0.59




28.3




0.281




7.63







1.68




13.7




0.38




7.96







0.94




25.9




0.43




6.62







1.41




21.6




0.51




5.66
















FIGS. 5A and 5B

illustrate a preferred embodiment where the tip


530


″ is displaced above the front side


522


″ of the needle


510


″. In

FIGS. 5A and 5B

, elements in common with those of the embodiment of

FIGS. 3-5

are similarly numbered (and need not be separately discussed beyond what follows) with the addition of a double apostrophe to distinguish the embodiments.




The needle


510


″ is 0.012 inch (about 0.3048 mm or 30 gauge) outside diameter. The preferred embodiment was derived following experimentation subsequent to that enumerated in the above table. In

FIG. 5B

, the bend angle θ is the lesser included angle of a straight line A tangent to the bent portion


600


″ and an extension line B of the straight portion. The distance Y is the distance between the tip


530


″ and the straight line extension B. The distance X is the distance from the intersection of the tangent line A and straight line extension B to the tip


530


″. All of the data in the following table illustrate fluid collection rate (measured in micro-liters per second, μl/sec.) as measured using a preferred value of X equal to 0.035 inch (about 0.8890 mm). The negative values for θ and Y represent a downward bend. Positive values represent upward bends as illustrated in

FIG. 5B. A

zero value represents an unbent needle.












TABLE B











Fluid Collection Rate (Micro-Liters/Second)














VALUES of Y


















Bend




−.006




.000




.005




.012




.016




.020






Angle




inch




inch




inch




inch




inch




inch






(θ) in




(≅−.1524




(≅.0000




(≅.1270




(≅.3048




(≅.4064




(≅.5080






degrees




mm)




mm)




mm)




mm)




mm)




mm)




















−8.1




0.06











0.0





0.10






4.6






0.13






6.5






0.13






7.1







0.12






7.6






0.10






10.0






0.14






12.2







0.15






12.2







0.13






12.8








0.16






14.9







0.13






16.8







0.13






20.0









0.19






21.6









0.17






21.8







0.16






24.7








0.19






25.6







0.18






26.6







0.15






31.2









0.20






46.4









0.20














Using the above data,

FIG. 9

is a graphical representation of the collection rate (μl/sec.) as a function of the Y displacement (where Y is the average Y values for various angles from the data in FIG. θ).

FIG. 10

is a scatter chart of the data plotted as collection rate (μl/sec.) as a function of the bend angle θ.




The above data show for a small gauge needle, collection rate improves with increases in both the bend angle θ and the displacement Y. In fact, displacements greater than the needle's outside diameter of 0.012 inch (representing a bending of the tip


530


″ above the front side


522


″ of the needle


510


″) shows improved collection rates.




Since pain avoidance is a desirable feature, patients selected to collect the above data were asked to compare pain sensation using the above-configured needles. While pain is subjective, it was surprising to note the patient population did not record appreciable increase in pain until the bend angle θ exceeded 30°—40°. The data suggest optimum design of a low pain needle for maximizing fluid collection rates is to provide a bend angle θ of about 30° and preferably between 20° and 40° with the tip


530


″ of the needle bent above the plane of the needle


510


″.




In certain applications (for example, collecting interstitial fluid for testing), it is desirable for the fluid to have a low blood content so as to be substantially blood-free. By substantially blood free, it is meant a sample with a hemocrit content of less than 10%. Using the bent needle


510


″ as described, the frequency of occurrence of blood in a sample increases compared to a straight needle, but the samples continue to be substantially blood free. The present needle


510


″ can also be used to collect higher blood content samples. In both, the design as described increases flow rate while retaining a low pain quality.




In addition to the bend angle described above, the needle


510


is dulled at the penetration end. The dulled edges at the penetration end have benefits separate from the displaced tip described above. Specifically, the dulled edges are found to reduce the amount of unwanted blood in a collected sample of interstitial fluid.





FIGS. 6-8

, illustrate a needle having a straight tip before and after its edges are dulled. Although the dulled edges are illustrated on a needle having a straight tip, they also could be used in conjunction with a displaced tip as described above. Elements and structures that are in common with the embodiments described above are marked with the same reference numerals with the addition of an apostrophe.




Referring now to

FIGS. 6 and 7

, the beveled face


520


′ is initially formed by grinding the needle


514


′ at the penetration end


600


′ as discussed above to form opening


521


′ (shown in FIG.


7


). This grinding forms an outer peripheral edge


630


′, which is defined by the intersection of the beveled face


520


′ and the outer surface of the cylindrical body


514


′. Additionally, an inner peripheral edge


632


′ is defined by the intersection of the beveled face


520


′ and the interior surface


511


′ of the needle body


514


′. Upon grinding the needle to form the beveled face


520


′, the inner and outer peripheral edges


630


′ and


632


′ and tip


530


′ are initially sharp (i.e., are formed at substantially non-rounded intersections).




After the beveled face


520


′ is formed, the inner and outer edges


630


′ and


632


′ and tip


530


′ are dulled so that they become burnished or radiused. The dulled edges are formed in a burnishing operation by tumbling the needle


510


′ in a tumbler with a polishing medium. In one possible embodiment, the polishing medium is a fine media such as 1 mm ceramic spheres and a soap solution. About 5,000 needles are tumbled in a single batch in the polishing medium for about 20 minutes. Other possible tumbling methods use a different polishing medium, different batch sizes, or different lengths of time.




Referring to

FIG. 8

, this process dulls the inner and outer edges


630


′ and


632


′ and tip


530


′. In one possible embodiment, the edges


630


′ and


632


′ and tip


530


′ are dulled to a radius of about 0.002 inch or about 0.05 mm. Although a burnishing process is described herein, manufacturing processes other than tumbling may be used to form the dulled edges.




From the foregoing detailed description, the present invention has been described in a preferred embodiment. Modifications and equivalents of such disclosure are intended to be included in the appended claims. For example, the benefits of the displaced tip can be attained without the dulled edges of the needle. Similarly, the benefits of the dulled edges can be attained without the displaced tip of the needle. Additionally, all needles have been shown with a single bevel. Nevertheless, the present invention is applicable to a needle with multiple bevels.



Claims
  • 1. A method of forming a needle having a bent tip, the method comprising: providing a body having a wall defining a lumen and an exterior surface, said body comprising a penetration end having a beveled face wherein the intersection of said beveled face and said wall forms a penetration tip; andbending said beveled face to displace said penetration tip beyond said exterior surface.
  • 2. The method of claim 1 wherein:said body has a front side and a back side and said beveled face is positioned on said front side; and said beveled face is bent at an angle in the range from about 20° and about 40°.
  • 3. The method of claim 1 wherein said bending comprises:placing a fulcrum at a selected location on said beveled face; urging said beveled face towards said fulcrum whereby said beveled face is bent at said selected location and said penetration tip is displaced beyond said exterior surface.
  • 4. The method of claim 1 wherein said beveled face has inner and outer peripheral edges, the method further comprising:dulling said inner and outer peripheral edges.
CROSS-REFERENCE TO RELATED APPLICATION

This application is a divisional of U.S. patent application Ser. No. 09/427,161, filed Oct. 26, 1999, U.S. Pat. No. 6,702,791, which is a continuation-in-part of U.S. patent application Ser. No. 09/244,952, filed Feb. 4, 1999, now abandoned the disclosures of which are hereby incorporated by reference.

US Referenced Citations (25)
Number Name Date Kind
2409979 Huber Oct 1946 A
2697438 Hickey Dec 1954 A
2717599 Huber Sep 1955 A
2748769 Huber Jun 1956 A
3872806 Bone Mar 1975 A
3906932 Ayres Sep 1975 A
3924617 Ferro Dec 1975 A
4368738 Tersteegen et al. Jan 1983 A
4383530 Bruno May 1983 A
4490139 Huizenga et al. Dec 1984 A
4518383 Evans May 1985 A
4753641 Vaslow Jun 1988 A
4788986 Harris Dec 1988 A
4799494 Wang Jan 1989 A
4808170 Thornton et al. Feb 1989 A
4889529 Haindl Dec 1989 A
5295980 Ersek Mar 1994 A
5403296 Mohring et al. Apr 1995 A
5505694 Hubbard et al. Apr 1996 A
5601475 Stametz et al. Feb 1997 A
5607401 Humphrey Mar 1997 A
5810788 Racz Sep 1998 A
5820570 Erickson et al. Oct 1998 A
5823973 Racchini et al. Oct 1998 A
6702791 Hilgers et al. Mar 2004 B1
Foreign Referenced Citations (2)
Number Date Country
0 872 215 Oct 1998 EP
WO 8202678 Aug 1982 WO
Non-Patent Literature Citations (3)
Entry
“Huber Needles & Infusion Sets”, Exel International, Inc., Internet 2 pages dated Dec. 15, 1998.
“Epidural Needles”, Manan Corp., Internet page dated Dec. 15, 1998.
“Tuohy Epidural Needle”, Dyna Medical Corp., Internet page dated Dec. 16, 1998.
Continuation in Parts (1)
Number Date Country
Parent 09/244952 Feb 1999 US
Child 09/427161 US